KEY CHARACTERISTICS • Faster processing speeds (up to 1,000 m/min) at low wall thickness (100 µm) • Increased chemical resistance • Lower gel migration • ECCOH 6153 UV - optimized for Teroson • ECCOH 6154 UV - optimized for Unigel • High color rendition and compatibility with Avient masterbatch • High UV resistance • Very low shrinkage MARKET & APPLICATIONS Optical Fiber Cables including: • Stranded loose tubes – gel-filled/dry • Micro-modules • Tight buffer applications – gel-filled/dry STANDARD COMPLIANCE • IEC 60794 • NF XP C93-850-1-1:2020 • EN 50289-4-17:2016 • ISO 4892:2016 • ST/CNET/5843 (1998) PRODUCT BULLETIN GEL MIGRATION PERFORMANCE ECCOH LSFOH 6153/6154 UV grades offer greater gel migration performance compared to alternative ECCOH grades.

ECCOH™ LOW SMOKE AND FUME, NON-HALOGEN FORMULATIONS PRODUCT SELECTION GUIDE ECCOH™ Low Smoke and Fume, Non-Halogen Solutions *Dry Silane abbreviated as DS **Cross-linked using Sioplas method 5549 UV Teck-90 5700 5801 UV 5865 5982 UV 6010 6151 6638 UV XLS 8001 APPLICATION Type Jacket Jacket Jacket Jacket Jacket Jacket Insulation Tight buffer, Micro-tube Jacket Jacket CABLE Type LV, Data LV LV, Data, OFC LV, Data, OFC Data, OFC LV, OFC LV OFC Data, OFC LV MARKETS Type B & C, Industrial Industrial, Teck-90 B & C, Industrial Industrial, Oil & Gas, Shipboard B & C B & C, Industrial Automotive B & C, Industrial B & C, Industrial B & C, Shipboard Cross-linked No No No Yes No No Yes No No Yes Cross-linking Method* N/A N/A N/A DS/E-beam N/A N/A DS/E-beam N/A N/A Sioplas GENERAL PROPERTIES Properties as Thermoset x x x SG g/cm³ 1.59 1.54 1.60 1.50 1.57 1.52 1.38 1.46 1.48 1.48 MFI, 150°C/21.6 Kg g/10 min 2.8 5 6 3.5 4 5.9 4.4 6 3 6 Hardness Shore D 44 54 50 46 50 54 56 53 53 49 Tensile psi 1740 2610 1595 1800 1740 2320 3336 2466 2030 2030 Elongation % 160% 200% 136% 133% 180% 150% 145% 160% 175% 160% LOI % 45% 36% 51% 39% 45% 41% 30% 33% 42% 33% Low temp brittleness (LTB) °C -26.5°C -49°C -10.5°C -30°C -39°C -38.5°C -41°C -35.5°C -26 -40.5 Max.

DOCUMENT NUMBER_ SSS-001 CATEGORY DETAIL EC Number 215-609-9 CAS Number 1333-86-4 Name Subclass 1 Carbon Black Structural Formula CHEMICAL IDENTITY H | C||||HH H DOCUMENT NUMBER_ SSS-001 HEALTH EFFECTS HUMAN HEALTH SAFETY ASSESSMENT Consumer Overall, as a result of the detailed epidemiological investigations, no causative link between Carbon Black exposure and cancer risk in humans has been demonstrated.

Recycle Loop AAnchor Mg/kg Anthranilamide Mg/kg Virgin

KEY CHARACTERISTICS • Compliant with BPR EU No. 528/2012 PT19 requirements • Designed for incorporation into cable jackets exposed to rats and termites attack • Efficacy at low dosing 2–4% • “Low concern” and long lasting active substance • Compatible with most polymers TARGET MARKET AND APPLICATIONS Appropriate for all applications where cables can be exposed to rats and termites.

Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for: (1) exposure to human tissue or body fluids for 30 days or greater; (2) “plastic” (cosmetic or reconstructive) surgery use; (3) reproductive implants or any birth control device; or (4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life.

Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for: (1) exposure to human tissue or body fluids for 30 days or greater; (2) “plastic” (cosmetic or reconstructive) surgery use; (3) reproductive implants or any birth control device; or (4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life.

https://www.avient.com/investors https://edge.media-server.com/mmc/p/xkwywv44 https://www.avient.com/investors https://register.vevent.com/register/BI3163094c31c24a9680e9118cec4f9167 https://www.avient.com/investors/events-presentations https://www.avient.com/news 4 About Avient Avient Corporation (NYSE: AVNT) provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. 2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and changes to valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) March 31, 2023 December 31, 2022 ASSETS Current assets: Cash and cash equivalents $ 582.7 $ 641.1 Accounts receivable, net 484.4 440.6 Inventories, net 371.9 372.7 Other current assets 125.3 115.3 Total current assets 1,564.3 1,569.7 Property, net 1,045.7 1,049.2 Goodwill 1,689.7 1,671.9 Intangible assets, net 1,601.7 1,597.6 Other non-current assets 209.8 196.6 Total assets $ 6,111.2 $ 6,085.0 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term debt $ 2.2 $ 2.2 Accounts payable 448.1 454.4 Accrued expenses and other current liabilities 386.9 412.8 Total current liabilities 837.2 869.4 Non-current liabilities: Long-term debt 2,177.7 2,176.7 Pension and other post-retirement benefits 66.2 67.2 Deferred income taxes 332.5 342.5 Other non-current liabilities 329.0 276.4 Total non-current liabilities 2,905.4 2,862.8 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,349.8 2,334.5 Noncontrolling interest 18.8 18.3 Total equity 2,368.6 2,352.8 Total liabilities and equity $ 6,111.2 $ 6,085.0 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Three Months Ended March 31, 2023 2022 Operating Activities Net income $ 20.4 $ 84.5 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 48.7 35.7 Accelerated depreciation 1.8 2.1 Share-based compensation expense 3.2 3.2 Changes in assets and liabilities, net of the effect of acquisitions: Increase in accounts receivable (40.2) (118.8) Decrease (increase) in inventories 3.8 (15.1) (Decrease) increase in accounts payable (9.9) 90.5 Accrued expenses and other assets and liabilities, net (50.0) (63.2) Net cash (used) provided by operating activities (22.2) 18.9 Investing activities Capital expenditures (20.3) (13.3) Net proceeds from divestiture 7.3 — Net cash used by investing activities (13.0) (13.3) Financing activities Purchase of common shares for treasury — (15.8) Cash dividends paid (22.5) (21.7) Repayment of long-term debt (0.8) (2.4) Other financing (2.3) (3.9) Net cash used by financing activities (25.6) (43.8) Effect of exchange rate changes on cash 2.4 (0.4) Decrease in cash and cash equivalents (58.4) (38.6) Cash and cash equivalents at beginning of year 641.1 601.2 Cash and cash equivalents at end of period $ 582.7 $ 562.6 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

Information should not be regarded as “public” until at least 24 hours after it has been published by a national news medium or has otherwise become available through an official news release or official announcement. 4. Covered Employees and their Related Persons may 4 not trade in Company securities during the period beginning on the last day of each quarter and ending after the first full business day following the official, public release of quarterly and year-end financial results, as applicable.

Feb 10, 2025